Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Twist Bioscience Corp TWST

Healthcare Biotechnology
Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that develops manufacturing synthetic DNA by writing DNA on a silicon chip. The Company leverages its technology to manufacture a broad range of... see more

Recent & Breaking News (NDAQ:TWST)

TWST Investors Have Opportunity to Lead Twist Bioscience Corporation Securities Fraud Lawsuit

PR Newswire February 6, 2023

Lead Plaintiff Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed against Twist Bioscience Corporation

Newsfile February 6, 2023

FRIDAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in Twist Bioscience Corporation with Losses of $100,000 to Contact the Firm

Newsfile February 6, 2023

DEADLINE ALERT: Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 10, 2023 in Twist Lawsuit - TWST

Newsfile February 6, 2023

Twist Shareholder Action Reminder

Newsfile February 5, 2023

TWIST BIOSCIENCE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Twist Bioscience Corporation - TWST

PR Newswire February 3, 2023

TWST NOTICE: ROSEN, A RESPECTED AND LEADING FIRM, Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important February 10 Deadline in Securities Class Action - TWST

Newsfile February 3, 2023

Twist Deadline Alert

Newsfile February 3, 2023

7-DAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in Twist Bioscience Corporation with Losses of $100,000 to Contact the Firm

Newsfile February 3, 2023

Twist Bioscience Reports Fiscal First Quarter 2023 Financial Results

Business Wire February 3, 2023

TWST SHAREHOLDER ALERT: Jakubowitz Law Reminds Twist Shareholders of a Lead Plaintiff Deadline of February 10, 2023

PR Newswire February 3, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Twist Bioscience Corporation - TWST

Newsfile February 2, 2023

TWST Deadline Alert: ROSEN, National Trial Lawyers, Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important February 10 Deadline in Securities Class Action - TWST

Newsfile February 2, 2023

Important February 10, 2023 Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Twist Bioscience Corporation Investors of Securities Fraud Class Action Lawsuit

Newsfile February 2, 2023

Twist Class Action: Levi & Korsinsky Reminds Twist Bioscience Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 10, 2023 - TWST

Newsfile February 2, 2023

HAGENS BERMAN Alerts Twist Bioscience (TWST) Investors to Feb. 10th Deadline in Securities Class Action, Urges Investors with Losses to Contact Firm's Attorneys

Newsfile February 2, 2023

TWST LAWSUIT ALERT: Levi & Korsinsky Notifies Twist Bioscience Corporation Investors of a Class Action Lawsuit and Upcoming Deadline

PR Newswire February 2, 2023

FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Twist Bioscience Corporation - TWST

PR Newswire February 1, 2023

Twist Shareholder Notice

Newsfile February 1, 2023

DEADLINE ALERT: Levi & Korsinsky Reminds Shareholders Of a Lead Plaintiff Deadline of February 10, 2023 in Twist Lawsuit - TWST

Newsfile February 1, 2023